Tempus AI, Inc. (TEM) Stock Analysis
Recovery setup
Healthcare · Health Information Services
Sell if holding. Engine safety override at $54.56: Quality below floor (3.1 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.3/10. Specifically: High short interest: 28%; Elevated put/call ratio: 1.62; Below-average business quality.
Tempus AI is an AI-enabled healthcare company providing genomic diagnostic testing (oncology, hereditary) and data licensing to pharmaceutical/biotech companies, with five U.S. diagnostic labs and 700+ data connections to healthcare institutions. Revenue derives from Diagnostics... Read more
Sell if holding. Engine safety override at $54.56: Quality below floor (3.1 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.3/10. Specifically: High short interest: 28%; Elevated put/call ratio: 1.62; Below-average business quality. Chart setup: Death cross but MACD improving, RSI 68. Score 5.3/10, moderate confidence.
Passes 3/7 gates (clean insider activity, no SEC red flags, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA) and earnings proximity 5d<=7d. Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHProductoncology and hereditary tests74%10-K Item 1A: 'our clinical oncology and hereditary tests, which collectively accounted for 74%, 63% and 63% of our revenue in the years ended December 31, 2025, 2024 and 2023, respectively'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
4 floor-breakers·1 ceiling hit
Volatile — 6.7% daily ATR makes tight stops impractical. Position-size conservatively.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Unprofitable operations — net margin -19.3%. Quality floor flags this regardless of sector context.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $54.56: Quality below floor (3.1 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.3/10. Specifically: High short interest: 28%; Elevated put/call ratio: 1.62; Below-average business quality. Chart setup: Death cross but MACD improving, RSI 68. Prior stop was $50.86. Score 5.3/10, moderate confidence.
Take-profit target: $65.16 (+19.1% upside). Prior stop was $50.86. Stop-loss: $50.86.
Concentration risk — Product: oncology and hereditary tests (74.0%); Quality below floor (3.1 < 4.0); Value-trap signals (2/5): High leverage (D/E 2.2), Material insider selling (26 sells, 0.14% of cap).
Tempus AI, Inc. trades at a P/E of N/A (forward -553.3). TrendMatrix value score: 6.7/10. Verdict: Sell.
23 analysts cover TEM with a consensus score of 3.9/5. Average price target: $72.
What does Tempus AI, Inc. do?Tempus AI is an AI-enabled healthcare company providing genomic diagnostic testing (oncology, hereditary) and data...
Tempus AI is an AI-enabled healthcare company providing genomic diagnostic testing (oncology, hereditary) and data licensing to pharmaceutical/biotech companies, with five U.S. diagnostic labs and 700+ data connections to healthcare institutions. Revenue derives from Diagnostics and Data & Applications product lines. The company had an accumulated deficit of $2.4B and net loss of $245.0M in 2025.